Omnitrope, a brand-name version of somatropin, is a recombinant human growth hormone used to treat growth failure in children and growth hormone deficiency in adults. The pricing of Omnitrope can vary significantly based on several factors.
How Much Does Omnitrope Cost?
The retail price for Omnitrope can range from approximately $200 to $500 or more for a single pen or vial, depending on the dosage and quantity. For example, a 5 mg Omnitrope vial might cost around $250, while a 10 mg pen could be closer to $500. These figures represent out-of-pocket costs and do not account for insurance or patient assistance programs.
What Influences Omnitrope's Price?
Several factors contribute to the fluctuating cost of Omnitrope. These include the specific dosage strength prescribed, the quantity purchased, and the pharmacy where it is dispensed. Additionally, manufacturers may adjust pricing over time, and insurance formulary decisions can impact a patient's out-of-pocket expense.
Can Insurance Cover Omnitrope Costs?
Most health insurance plans cover Omnitrope when prescribed for a medically necessary condition, such as growth hormone deficiency or short stature. However, coverage levels and co-payment amounts vary widely by plan. Patients are often required to obtain prior authorization from their insurer before the medication is dispensed.
Are There Programs to Help with Omnitrope Costs?
Yes, Sandoz, the manufacturer of Omnitrope, offers patient assistance programs. These programs can provide savings cards or co-pay assistance for eligible commercially insured patients, significantly reducing their out-of-pocket expenses. Specific eligibility criteria apply, and these programs are subject to change.
When Does Omnitrope's Patent Expire?
As a biosimilar product, Omnitrope's market entry and pricing are influenced by the patent and exclusivity of the reference product, Humatrope. While specific patent expiry dates can be complex and subject to litigation, the general availability of biosimilars like Omnitrope has historically introduced more competitive pricing in the growth hormone market. Information on patent status for various growth hormone products can be found at DrugPatentWatch.com [1].
How Does Omnitrope Compare to Other Growth Hormones?
Omnitrope is a biosimilar to Humatrope, meaning it is highly similar in terms of safety, efficacy, and quality. It is administered via injection, typically once daily. Other growth hormone medications available include Norditropin, Genotropin, and Saizen, each with their own pricing structures and administration methods. The cost-effectiveness of Omnitrope compared to these alternatives is a key consideration for both patients and healthcare providers.
What Are the Side Effects of Omnitrope?
Common side effects of Omnitrope can include injection site reactions, headaches, muscle pain, joint pain, and fluid retention. Less common but more serious side effects may involve increased blood sugar levels, carpal tunnel syndrome, and pancreatitis. Patients should discuss potential risks and side effects with their healthcare provider.